Herein, we report that further to the previously published findings on PG545′s ability to interfere with angiogenic growth factors, this compound also inhibits Wnt signaling within tumor cells which leads to reduced levels of β-catenin, VEGF, MMP-7 and Cyclin D1 (Fig. 6). The gene discussed is VEGFA; the disease is neoplasm.